ANCHOR Trial

Multicenter, prospective and observational Trial. Percutaneous Coronary Intervention with the ANgiolite: an Optical CoHerence TOmogRaphy Study. 6 months outcomes. Published at Catheter Cardiovasc Interv. 2017;1-9.

Device: angiolite

Number of patients: 103

Follow up: 24 months

Type of lesion: de-novo lesions

In ANCHOR, angiolite demonstrated a favorable early healing profile assessed with OCT at 3 and 6-month post PCI.

This was characterized by high rates of strut coverage and very low rates of in-stent LLL.

Imaging data were also coupled with favorable 24-month clinical data characterized by the absence of binary in-stent restenosis, stent thrombosis, myocardial infarction or cardiac death, suggesting a highly efficacy of angiolite.

These low rates are demonstrating an excellent stent performance

Dr. Josep Rodés-Cabau (PI) – Quebec Heart and Lung Institute (Quebec, CAN)

All Clinicals Trials
ANGIOLITE Trial
RANGO Registry